12 results
DEFA14A
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Additional proxy soliciting materials
4:06pm
, necessity, or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, AMTI specifically denies all allegations
8-K
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Other Events
4:05pm
of the legal merit, necessity, or materiality under applicable laws of any of the disclosures set forth herein. To the contrary, AMTI specifically denies all
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
and Cyclo expect to evaluate the materiality of any waiver and its effect on AMTI or Cyclo stockholders in light of the facts and circumstances at the time … to a contractual standard of materiality which may differ from what may be viewed as material by investors. In particular, in your review of the representations
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
are not reflected in the Merger Agreement itself; may no longer be true as of a given date; and may apply standards of materiality in a way … qualification by materiality or Company Material Adverse Effect contained therein) that would not, individually, or in the aggregate, reasonably
8-K
6nnur8 tbhgfjzk
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
EX-2.1
hw5peg9
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
84gce0e740qzrhuk495p
18 May 22
Applied Molecular Transport Provides Strategy Update
8:18am
S-3
EX-5.1
z2orxaovl
11 Mar 22
Shelf registration
5:03pm
8-K
EX-1.1
tyi11aq 7c4p
28 Jan 22
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next